Clinical Otolaryngology最新文献

筛选
英文 中文
Redress and Reflection Regarding Socioeconomic Inequality in the Head and Neck Cancer Referral System. 头颈部肿瘤转诊系统中社会经济不平等的纠正与反思。
IF 1.7 4区 医学
Clinical Otolaryngology Pub Date : 2024-12-25 DOI: 10.1111/coa.14267
Thomas Hampton, Andrew Lau
{"title":"Redress and Reflection Regarding Socioeconomic Inequality in the Head and Neck Cancer Referral System.","authors":"Thomas Hampton, Andrew Lau","doi":"10.1111/coa.14267","DOIUrl":"https://doi.org/10.1111/coa.14267","url":null,"abstract":"","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142892452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distraction Therapies for Office-Based Otolaryngology Procedures Performed on the Upper Airway 在上呼吸道进行的办公室耳鼻喉科手术的分散治疗。
IF 1.7 4区 医学
Clinical Otolaryngology Pub Date : 2024-12-24 DOI: 10.1111/coa.14270
Tanika Curry, Andrea Lasso, Shaun Kilty
{"title":"Distraction Therapies for Office-Based Otolaryngology Procedures Performed on the Upper Airway","authors":"Tanika Curry,&nbsp;Andrea Lasso,&nbsp;Shaun Kilty","doi":"10.1111/coa.14270","DOIUrl":"10.1111/coa.14270","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To assess the effectiveness of auditory and visual distraction interventions on patient discomfort, pain and anxiety during office-based otolaryngologic upper airway procedures.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data Sources</h3>\u0000 \u0000 <p>Literature searches were done through Cochrane Central Register of Controlled Trials, Lilacs, MEDLINE, Embase, PsycINFO and Cumulative Index to Nursing and Allied Health Literature.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Review Methods</h3>\u0000 \u0000 <p>The protocol was registered in PROSPERO on August 17th 2022, under Registration number CRD42020204354.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We identified 138 records; two randomised controlled trials using virtual reality as a distraction technique in adults and one in children were included. All studies had some concerns regarding risk of bias. In adults, anxiety was lower in the virtual reality group than in the standard of care, (mean difference −16.72, 95% CI −27.19 to −6.24, <i>p</i> = 0.002, <i>I</i>\u0000 <sup>2</sup> = 0%). There was no difference in procedure related pain between groups, (mean difference −0.28, 95% CI −1.24 to 0.68, <i>p</i> = 0.57, <i>I</i>\u0000 <sup>2</sup> = 10%). There was no difference in satisfaction between groups (standardised mean difference 0.18, 95% CI −0.22 to 0.58, <i>p</i> = 0.37, <i>I</i>\u0000 <sup>2</sup> = 0%). Only one Paediatric study was included hence no meta-analysis was done. Anxiety and pain were lower and satisfaction was higher in the group using virtual reality.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The use of virtual reality distraction in addition to standard analgesia during office-based otolaryngology upper airway procedures reduced anxiety in adults. It did not decrease pain or increase the level of patient satisfaction. In the paediatric population, there is a reported benefit for procedural anxiety, pain and satisfaction.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"50 2","pages":"241-248"},"PeriodicalIF":1.7,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/coa.14270","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142881409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should Diagnostic Rigid Oesophagoscopy Continue to Form Part of Panendoscopy? 诊断性硬食道镜应该继续成为全内镜检查的一部分吗?
IF 1.7 4区 医学
Clinical Otolaryngology Pub Date : 2024-12-23 DOI: 10.1111/coa.14266
S. A. R. Nouraei
{"title":"Should Diagnostic Rigid Oesophagoscopy Continue to Form Part of Panendoscopy?","authors":"S. A. R. Nouraei","doi":"10.1111/coa.14266","DOIUrl":"10.1111/coa.14266","url":null,"abstract":"","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"50 2","pages":"396-398"},"PeriodicalIF":1.7,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Using Perioperative Platelet-Rich Plasma on Wound Healing Rate and Prevention of Salivary Fistula Formation in Patients Undergoing Partial Parotidectomy 围手术期应用富血小板血浆对腮腺部分切除术患者创面愈合及预防唾液瘘形成的影响。
IF 1.7 4区 医学
Clinical Otolaryngology Pub Date : 2024-12-12 DOI: 10.1111/coa.14265
Selim Kul, Sema Zer Toros, Çağrı Becerik, Lütfü Şeneldir, Sebahat Aksaray
{"title":"The Effect of Using Perioperative Platelet-Rich Plasma on Wound Healing Rate and Prevention of Salivary Fistula Formation in Patients Undergoing Partial Parotidectomy","authors":"Selim Kul,&nbsp;Sema Zer Toros,&nbsp;Çağrı Becerik,&nbsp;Lütfü Şeneldir,&nbsp;Sebahat Aksaray","doi":"10.1111/coa.14265","DOIUrl":"10.1111/coa.14265","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>This study aims to examine the effects of autologous platelet-rich plasma (PRP), which increases new connective tissue synthesis and revascularisation, on healing in parotid surgery wounds, prevention of salivary fistula formation, drain removal time and hospitalisation in the postoperative period.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>Fifty-four patients who had an operation on partial parotidectomy were randomised, and then two groups were created. PRP was obtained by centrifuging the blood taken from the patients in the study group at the end of the surgery. This obtained PRP was injected into the surgical site, and then the wound flap was closed by suturing. Patients were evaluated for parameters such as the development of salivary fistula, duration of drain removal, discharge time and all other complications during the postoperative 4 weeks.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Drain removal and discharge times of the PRP group cases were statistically shorter than those in the control group. The rate of development of a salivary fistula was remarkably high in the control group, but it was not statistically significant. A statistically significant correlation was found between the location of the compared tumour, the volume of material removed and the incidence of all complications.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>PRP reduced the duration of drain removal and discharge times for those who had an operation on partial parotidectomy. Thus, the decreased discharge time provides both reduced health costs and reduced risk of developing nosocomial infections. Although it was not statistically significant, a significant difference was observed in the rates of salivary fistula development.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"50 2","pages":"352-357"},"PeriodicalIF":1.7,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142817363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Stratification of Suspected Head and Neck Cancer Referral Letters: A Prospective Cohort Study 疑似头颈癌转诊信的风险分层:一项前瞻性队列研究。
IF 1.7 4区 医学
Clinical Otolaryngology Pub Date : 2024-12-12 DOI: 10.1111/coa.14269
Annabel Hill, Timothy Davies, Kate Howson, Jeffrey Lancaster, Katharine Davies
{"title":"Risk Stratification of Suspected Head and Neck Cancer Referral Letters: A Prospective Cohort Study","authors":"Annabel Hill,&nbsp;Timothy Davies,&nbsp;Kate Howson,&nbsp;Jeffrey Lancaster,&nbsp;Katharine Davies","doi":"10.1111/coa.14269","DOIUrl":"10.1111/coa.14269","url":null,"abstract":"","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"50 2","pages":"392-395"},"PeriodicalIF":1.7,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142812276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
‘How Long Do I Have?’ – Examining survival outcomes in laryngeal cancer patients managed with non-curative intent in Northern UK: Insights from the Northern Head & Neck Cancer Alliance Retrospective Study “我还有多长时间?”-检查英国北部非治愈目的喉癌患者的生存结果:来自北方头颈癌联盟回顾性研究的见解。
IF 1.7 4区 医学
Clinical Otolaryngology Pub Date : 2024-12-11 DOI: 10.1111/coa.14260
Amarkumar Rajgor, Rhona Hurley, Catriona M. Douglas, Claire Paterson, James Moor, Shane Lester, Sara Sionis, Katharine Davies, James O'Hara, Gareth Inman, Terry Jones, David Winston Hamilton, Northern Head & Neck Alliance
{"title":"‘How Long Do I Have?’ – Examining survival outcomes in laryngeal cancer patients managed with non-curative intent in Northern UK: Insights from the Northern Head & Neck Cancer Alliance Retrospective Study","authors":"Amarkumar Rajgor,&nbsp;Rhona Hurley,&nbsp;Catriona M. Douglas,&nbsp;Claire Paterson,&nbsp;James Moor,&nbsp;Shane Lester,&nbsp;Sara Sionis,&nbsp;Katharine Davies,&nbsp;James O'Hara,&nbsp;Gareth Inman,&nbsp;Terry Jones,&nbsp;David Winston Hamilton,&nbsp;Northern Head & Neck Alliance","doi":"10.1111/coa.14260","DOIUrl":"10.1111/coa.14260","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Historically, 15% of laryngeal cancer patients undergo non-curative management, but pragmatic data on this group are limited. This information is crucial to help patients make informed decisions about their care. Supported by the Northern Head &amp; Neck Alliance, this retrospective study is the first to present survival outcomes for non-curative laryngeal cancer patients in Northern UK.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Retrospective data were compiled for patients with laryngeal squamous cell cancer from five large tertiary head and neck centres in Northern UK (Newcastle, Glasgow, Sheffield, Leeds, and Middlesbrough). The collected data encompassed demographic details, treatment and clinical outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 373 patients, the mean age was 72, and 73% were male. The median follow-up was 6 months. 17% had early-stage (T1-2), and 83% had late-stage (T3-4) disease. By data collection, 99% had died.</p>\u0000 \u0000 <p>The mean survival time (MST) was 9.1 months. Patients with metastases had an MST of 6.9 months, while those without had 9.4 months. Early-stage patients had an MST of 13.3 months, compared to 8.2 months for advanced disease. By subsite, MSTs were 8.2 months for supraglottic, 12.5 for glottic, 5.5 for subglottic, and 7.9 for transglottic cancers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This study stands as the first to explore survival outcomes in laryngeal cancer patients undergoing non-curative management. The findings can provide valuable insights for informing patients about survival in the absence of radical treatment, facilitating important decision-making conversations.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"50 2","pages":"344-351"},"PeriodicalIF":1.7,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/coa.14260","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142806334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Distribution and Therapeutic Effectiveness of Clinical Unilateral Ménière's Disease Phenotypes 临床单侧msamniires病的表型分布及疗效分析。
IF 1.7 4区 医学
Clinical Otolaryngology Pub Date : 2024-12-04 DOI: 10.1111/coa.14264
Yongjia Chen, Xinzhang Cai, Yulu Zhang, Chufeng He, Xuewen Wu, Lu Jiang, Hongsheng Chen, Jing Liu, Bo Pang, Shuai Zhang, Anhai Chen, Mengzhu Jiang, Huping Huang, Yijiang Bai, Zequn Nie, Lingyun Mei
{"title":"The Distribution and Therapeutic Effectiveness of Clinical Unilateral Ménière's Disease Phenotypes","authors":"Yongjia Chen,&nbsp;Xinzhang Cai,&nbsp;Yulu Zhang,&nbsp;Chufeng He,&nbsp;Xuewen Wu,&nbsp;Lu Jiang,&nbsp;Hongsheng Chen,&nbsp;Jing Liu,&nbsp;Bo Pang,&nbsp;Shuai Zhang,&nbsp;Anhai Chen,&nbsp;Mengzhu Jiang,&nbsp;Huping Huang,&nbsp;Yijiang Bai,&nbsp;Zequn Nie,&nbsp;Lingyun Mei","doi":"10.1111/coa.14264","DOIUrl":"10.1111/coa.14264","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>The first purpose of this study was to ascertain the distribution of unilateral Ménière's disease (MD) clinical subgroups in China and compare with the population reported in Europe and the United States. The second purpose was to investigate the effectiveness in different clinical phenotypes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Participants were categorised into one of five subtypes using a previously reported classification scheme based on cluster analysis. The distribution and clinical characteristics were analysed and compared with the two cohorts reported in Europe and the United States. Participants were followed up to observe the therapeutic effectiveness over a 2-year period.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 245 patients diagnosed with UMD were enrolled in the study, with 84 of these participants providing complete and detailed follow-up data. All of the unilateral MD patients were accurately classified: 58.0% were classic MD, 25.7% were delayed MD, 1.2% was familial MD, 12.7% were sporadic MD with migraine and 2.4% were autoimmune MD. Our findings revealed a significant difference in the distribution between this cohort and the European cohort. Follow-up assessments revealed worse vertigo control rate in the patients with migraine compared to the classical MD (50.0% vs. 82.6%, <i>p</i> = 0.034).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The distribution of unilateral MD subtypes in this Chinese population differs from that in the European population, and the therapeutic effectiveness varies across subtypes in this cohort. Our study highlights the importance of the clinical heterogeneity in unilateral MD, and further studies are needed to identify the optimal interventions for specific subgroups.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"50 2","pages":"336-343"},"PeriodicalIF":1.7,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142766926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of Cholesteatoma in the UK Biobank 英国生物银行胆脂瘤的流行病学研究。
IF 1.7 4区 医学
Clinical Otolaryngology Pub Date : 2024-12-04 DOI: 10.1111/coa.14257
Emma Wilson, Barbara Anne Jennings, Mizanur Khondoker, Carl M. Philpott, Peter Prinsley, Daniel S. Brewer
{"title":"Epidemiology of Cholesteatoma in the UK Biobank","authors":"Emma Wilson,&nbsp;Barbara Anne Jennings,&nbsp;Mizanur Khondoker,&nbsp;Carl M. Philpott,&nbsp;Peter Prinsley,&nbsp;Daniel S. Brewer","doi":"10.1111/coa.14257","DOIUrl":"10.1111/coa.14257","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To identify factors associated with cholesteatoma in a large UK cohort. Although some risk factors are frequently reported (male sex, history of chronic otitis media), other associations require further evidence (deprivation, smoking).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design and Setting</h3>\u0000 \u0000 <p>Briefly, 1140 cholesteatoma cases from UK BioBank were compared to 4551 non-cholesteatoma middle ear disease and 493 832 ear disease-free controls. Adjusted odds ratios were calculated for demographic factors including age, sex, ethnicity, deprivation and smoking status with logistic regressions. Odds ratios for overlapping ICD-10 codes are also calculated.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Cholesteatoma was significantly associated with sex (Adjusted odds ratio (AOR) for males = 1.33, 95%CI = [1.179–1.491]), age (AOR = 1.02, 95%CI = [1.011–1.026]) and deprivation (AOR = 1.08, 95%CI = [1.059–1.097]) compared to ear disease-free controls (<i>p</i> &lt; 0.001). Age and deprivation distributions for cholesteatoma and non-cholesteatoma ear disease were similar. Although there was no significant association with smoking status, cholesteatoma was significantly associated with the ICD-10 code mental and behavioural disorders due to tobacco use (OR = 2.34, <i>p</i> &lt; 0.001, 95%CI = [1.942, 2.813]). Cholesteatoma was also strongly associated with a wide range of inflammatory middle ear conditions and chronic sinus inflammation, suggesting an increased susceptibility to inflammation of the upper airways.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This study shows a large overlap between cholesteatoma and non-cholesteatoma ear disease in terms of numbers and demographics, with sex being a key factor distinguishing between the two, suggesting that there are both common and distinct associated factors.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"50 2","pages":"316-329"},"PeriodicalIF":1.7,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/coa.14257","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142766923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Use of Fluorescent Markers to Detect and Delineate Head and Neck Cancer: A Scoping Review 使用荧光标记检测和划定头颈癌:范围综述。
IF 1.7 4区 医学
Clinical Otolaryngology Pub Date : 2024-12-04 DOI: 10.1111/coa.14263
Akash Srinivasan, Viktorija Kaminskaite, Stuart C. Winter
{"title":"The Use of Fluorescent Markers to Detect and Delineate Head and Neck Cancer: A Scoping Review","authors":"Akash Srinivasan,&nbsp;Viktorija Kaminskaite,&nbsp;Stuart C. Winter","doi":"10.1111/coa.14263","DOIUrl":"10.1111/coa.14263","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>The aim of surgery for head and neck squamous cell carcinoma (HNSCC) is to achieve clear resection margins, whilst preserving function and cosmesis. Fluorescent markers have demonstrated potential in the intraoperative visualisation and delineation of tumours, such as glioma, with consequent improvements in resection. The purpose of this scoping review was to identify and compare the fluorescent markers that have been used to detect and delineate HNSCC to date.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A literature search was performed using the Ovid MEDLINE, Ovid Embase, Cochrane CENTRAL, ClinicalTrials.gov and ICTRP databases. Primary human studies published through September 2023 demonstrating the use of fluorescent markers to visualise HNSCC were selected and reviewed independently by two authors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The search strategy identified 5776 records. Two hundred and forty-four full texts were reviewed, and sixty-five eligible reports were included. The most used fluorescent markers in the included studies were indocyanine green (ICG) (<i>n</i> = 14), toluidine blue (<i>n</i> = 11), antibodies labelled with IRDye800CW (<i>n</i> = 10) and 5-aminolevulinic acid (5-ALA) (<i>n</i> = 8). Toluidine blue and ICG both have limited specificity, although novel targeted options derived from ICG may be more effective. 5-ALA has been demonstrated as a topical marker and, recently, via enteral administration but it is associated with photosensitivity reactions. The fluorescently labelled antibodies cetuximab-IRDye800CW and panitumumab-IRDye800CW are promising options being investigated by ongoing trials.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Multiple safe fluorescent markers have emerged which may aid the surgical resection of HNSCC. Further research in larger cohorts is required to identify which marker should be considered gold standard.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"50 2","pages":"220-240"},"PeriodicalIF":1.7,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/coa.14263","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142766927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of Information Provided by Artificial Intelligence Chatbots Surrounding the Reconstructive Surgery for Head and Neck Cancer: A Comparative Analysis Between ChatGPT4 and Claude2 人工智能聊天机器人在头颈癌重建手术中提供的信息质量:ChatGPT4与Claude2的比较分析
IF 1.7 4区 医学
Clinical Otolaryngology Pub Date : 2024-12-04 DOI: 10.1111/coa.14261
Paolo Boscolo-Rizzo, Alberto Vito Marcuzzo, Chiara Lazzarin, Fabiola Giudici, Jerry Polesel, Marco Stellin, Andrea Pettorelli, Giacomo Spinato, Giancarlo Ottaviano, Marco Ferrari, Daniele Borsetto, Simone Zucchini, Franco Trabalzini, Egidio Sia, Nicoletta Gardenal, Roberto Baruca, Alfonso Fortunati, Luigi Angelo Vaira, Giancarlo Tirelli
{"title":"Quality of Information Provided by Artificial Intelligence Chatbots Surrounding the Reconstructive Surgery for Head and Neck Cancer: A Comparative Analysis Between ChatGPT4 and Claude2","authors":"Paolo Boscolo-Rizzo,&nbsp;Alberto Vito Marcuzzo,&nbsp;Chiara Lazzarin,&nbsp;Fabiola Giudici,&nbsp;Jerry Polesel,&nbsp;Marco Stellin,&nbsp;Andrea Pettorelli,&nbsp;Giacomo Spinato,&nbsp;Giancarlo Ottaviano,&nbsp;Marco Ferrari,&nbsp;Daniele Borsetto,&nbsp;Simone Zucchini,&nbsp;Franco Trabalzini,&nbsp;Egidio Sia,&nbsp;Nicoletta Gardenal,&nbsp;Roberto Baruca,&nbsp;Alfonso Fortunati,&nbsp;Luigi Angelo Vaira,&nbsp;Giancarlo Tirelli","doi":"10.1111/coa.14261","DOIUrl":"10.1111/coa.14261","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Artificial Intelligences (AIs) are changing the way information is accessed and consumed globally. This study aims to evaluate the information quality provided by AIs ChatGPT4 and Claude2 concerning reconstructive surgery for head and neck cancer.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Thirty questions on reconstructive surgery for head and neck cancer were directed to both AIs and 16 head and neck surgeons assessed the responses using the QAMAI questionnaire. A 5-point Likert scale was used to assess accuracy, clarity, relevance, completeness, sources, and usefulness. Questions were categorised into those suitable for patients (group 1) and those for surgeons (group 2). AI responses were compared using <i>t</i>-Student and McNemar tests. Surgeon score agreement was measured with intraclass correlation coefficient, and readability was assessed with Flesch–Kincaid Grade Level (FKGL).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>ChatGPT4 and Claude2 had similar overall mean scores of accuracy, clarity, relevance, completeness and usefulness, while Claude2 outperformed ChatGPT4 in sources (110.0 vs. 92.1, <i>p</i> &lt; 0.001). Considering the group 2, Claude2 showed significantly lower accuracy and completeness scores compared to ChatGPT4 (<i>p</i> = 0.003 and <i>p</i> = 0.002, respectively). Regarding readability, ChatGPT4 presented lower complexity than Claude2 (FKGL mean score 4.57 vs. 6.05, <i>p</i> &lt; 0.001) requiring an easy-fairly easy English in 93% of cases.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Our findings indicate that neither chatbot exhibits a decisive superiority in all aspects. Nonetheless, ChatGPT4 demonstrates greater accuracy and comprehensiveness for specific types of questions and the simpler language used may aid patient inquiries. However, many evaluators disagree with chatbot information, highlighting that AI systems cannot serve as a substitute for advice from medical professionals.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10431,"journal":{"name":"Clinical Otolaryngology","volume":"50 2","pages":"330-335"},"PeriodicalIF":1.7,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/coa.14261","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142766924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信